Healthcare Integration: A Work in Progress – Questrom’s Sixth Annual Health & Life Sciences Conference
Posted November 2, 2018| Robert Flynn
Fuld + Company, Principal, Bob Flynn will be presenting at the Questrom’s Sixth Annual Health & Life Sciences Conference
Friday, November 2, 2018 | Boston University Questrom School of Business
Panel: Business Development: Partnerships & Collaboration
As more and more firms in the healthcare space consolidate, organizations are beginning to see the value in partnership for the sake of business development. Though many small biotechnology firms license out to big pharmaceutical companies in the interests of commercialization, the trend is showing that partnerships are spanning industry borders. This includes insurance companies leveraging the booming technology industry, and drug companies seeking a way to cushion the fall from their approaching patent cliffs. This panel will seek to explore how stakeholders pursue these partnerships, from the execution of due diligence to the negotiation of profit-sharing, and whether this consolidation is driving the innovation society needs.
David Barone, BSc, MSc, Biomedical Engineering, MBA | Pricinpal, Boston MedTech Advisors
Robert Flynn, MBA, MA, BA | Principal, Fuld + Company
Jonathan Rea, MBA, BBA | Director of Business Development, Boston Scientific Endoscopy
Kareem Reda, MBA, BS | Head of Business Development and Corporate Strategy, Evelo Biosciences, Inc.,
Devin Nadar, BA | Partnership Manager, Innovation & Digital Health Accelerator, Boston Children’s
Fuld + Company’s Life Science Consulting practice spans pharmaceuticals, biotechnology, diagnostics, medical device, health IT, and healthcare payers and providers.